711 filings
Page 32 of 36
8-K
lvwlaj1wa6es4cg6t
9 Feb 16
KemPharm Announces Pricing of $75.0 Million 5.50% Senior Convertible Notes Due 2021
12:00am
RW
jj143 odl97pur8j
3 Feb 16
Registration withdrawal request
12:00am
8-K
tzh3ljw3ozt wxk
11 Jan 16
Entry into a Material Definitive Agreement
12:00am
8-K
olq6cdhjw16l3rv0kmis
30 Dec 15
KemPharm, Inc. Expands Pain Therapy Pipeline with Discovery of KP746
12:00am
8-K
u93vr4b
18 Dec 15
Entry into a Material Definitive Agreement
12:00am
SC 13G/A
z8vrk057yr75bf ejz0
18 Dec 15
Kempharm, Inc
12:00am
8-K
m14hmq sfz697k41t
15 Dec 15
Regulation FD Disclosure
12:00am
8-K
n965v8x54qjr
8 Dec 15
Other Events
12:00am
8-K
sdvdic 8ig94fhah2zrr
12 Nov 15
KemPharm, Inc. Reports Q3 2015 Results
12:00am
4
pxqulqnnrr4zq18dyz6o
30 Oct 15
KEMPHARM / Travis C Mickle ownership change
12:00am
4
5fbhfepo
30 Oct 15
KEMPHARM / Christal M M Mickle ownership change
12:00am
SC 13G
hgt63k057 7if
28 Oct 15
Kempharm, Inc
12:00am
8-K
902c wfgcvc2zadsy
21 Oct 15
KemPharm, Inc. Completes Human Abuse Liability Program for KP201/APAP
12:00am
8-K
pw6j3o0j 3akmr8d073v
15 Oct 15
Unregistered Sales of Equity Securities
12:00am
8-K
s2fyf5vionl
30 Sep 15
KemPharm Reports Positive Data Demonstrating Tamper-Resistant Properties of KP201/APAP
12:00am
8-K
gk6l07oteoxil js4g9q
24 Sep 15
Provides Updates on Clinical Development Pipeline and Anticipated NDA Filings
12:00am
8-K
5pcxi w42
23 Sep 15
Other Events
12:00am
4
dcp0ju2z93vtz c4dwo
9 Sep 15
KEMPHARM / Travis C Mickle ownership change
12:00am